Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gregory Arnsdorff, Nefertiti Greene, Brian Miller, Rick Brajer, Stephen Stamp


AdvaMedDx, a division of the Advanced Medical Technology Association, announced the election of several new members to its board of directors. The new board members are: Gregory Arnsdorff, VP of Abbott Laboratories and president of Abbott Point of Care; Nefertiti Greene, VP of US diabetes care at Bayer HealthCare Diabetes Care; Brian Miller, managing partner at Linden Capital Partners; and Rick Brajer, president and CEO of LipoScience.

AssureRx Health has appointed Stephen Stamp as its senior VP and CFO and Jeffrey Bush as if VP of payor markets and reimbursement. Stamp comes to AssureRx from EZCorp, where he was CFO. Bush joins AssureRx from Becton, Dickinson and Company, where he served as senior director of reimbursement strategy and payment policy.

According to the AssureRx, the new appointments come as demand for its GeneSight pharmacogenomic testing service is increasing.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.